Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT07691658
Active, not recruiting Not applicable

Clinical Evaluation of Prefabricated Versus 3D-Printed Composite Resin Veneers: in Vivo Study

NCT07691658 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-04-25
Last updated
2026-07-09

Condition(s) studied

VeneerComposite RestorationsTeeth ColorTeeth Staining

Investigational drug(s) / intervention(s)

Prefabricated Composite Resin Veneers3D-Printed Composite Resin Veneers

Prefabricated Composite Resin Veneers: Prefabricated composite resin veneer restorations used for esthetic rehabilitation of anterior teeth. Restorations will be bonded following the manufacturer's recommended adhesive protocol.

3D-Printed Composite Resin Veneers: Customized 3D-printed composite resin veneer restorations fabricated using digital design and additive manufacturing technology and bonded according to the manufacturer's recommended adhesive protocol

Study summary

The purpose of this study is to clinically evaluate prefabricated versus 3D-printed composite resin veneers

Eligibility

Sex
ALL
Min age
20 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Good oral hygiene and satisfactory periodontal health * Patients requiring esthetic rehabilitation of anterior teeth * Presence of enough enamel for bonding Exclusion Criteria: * Non-vital teeth or teeth requiring endodontic treatment * Severe malocclusion or parafunctional habits (e.g., bruxism or clenching) * Patients with severe intrinsic discoloration requiring alternative treatment

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Restorative Department, Faculty of Dentistry, Tanta University Tanta Tanta

More Tanta University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07691658 on ClinicalTrials.gov ↗ ← All trials in Egypt